Aspirin versus aggressive antiplatelet therapy for acute carotid stenting plus thrombectomy in tandem occlusions: ETIS Registry results.
In: Journal of NeuroInterventional Surgery, Jg. 15 (2023-11-02), S. e248- (94S.)
academicJournal
Zugriff:
Background Patients treated with acute carotid stenting (CAS) may have higher odds of a favorable outcome than those treated without CAS during thrombectomy in tandem occlusions. Antiplatelet therapy is associated with CAS to avoid stent thrombosis, which occurs in around 20% of patients and negatively impacts outcomes. In this study we compared two antiplatelet strategies in tandem occlusion strokes treated with CAS and intracranial thrombectomy in clinical practice. Methods The Endovascular Treatment in Ischemic Stroke Registry is an ongoing prospective observational study involving 21 comprehensive stroke centers performing thrombectomy in France. We analyzed patients with atherosclerotic tandem occlusions treated with acute CAS and intracranial thrombectomy who received at least one antiplatelet agent. Aggressive antiplatelet therapy included oral or intravenous glycoprotein (GP) IIb/IIIa or P2Y12 inhibitors. The primary outcome was cervical carotid artery patency at day 1 imaging follow-up. Results Among the 187 included patients, 124 (66.3%) received aspirin alone and 63 (33.7%) received aggressive antiplatelet therapy. There was no significant difference regarding safety outcomes, especially in symptomatic intracerebral hemorrhage, parenchymal hematoma, and procedural complications. There was a significantly higher rate of carotid stent patency at day 1 in the aggressive antiplatelet therapy group (81.7% vs 97.1%, aOR 17.49, 95% CI 1.10 to 277.2, p=0.042). Odds of favorable functional outcome (90-day modified Rankin Scale score 0-2) were similar between the groups (OR 3.04, 95% CI 0.64 to 14.25, p=0.158). Conclusions In tandem occlusions treated with CAS plus thrombectomy, an aggressive antiplatelet regimen was associated with an increased rate of carotid stent patency at day 1 without safety concerns. Randomized trials are warranted to confirm these findings. [ABSTRACT FROM AUTHOR]
Copyright of Journal of NeuroInterventional Surgery is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Aspirin versus aggressive antiplatelet therapy for acute carotid stenting plus thrombectomy in tandem occlusions: ETIS Registry results.
|
---|---|
Autor/in / Beteiligte Person: | Marnat, Gaultier ; Finistis, Stefanos ; Moreno, Ricardo ; Sibon, Igor ; Pop, Raoul ; Mazighi, Mikaël ; Clarençon, Frédéric ; Rosso, Charlotte ; Dargazanli, Cyril ; Darcourt, Jean ; Olivot, Jean-Marc ; Boulouis, Gregoire ; Janot, Kevin ; Moulin, Solène ; Bourcier, Romain ; Consoli, Arturo ; Richard, Sébastien ; Arquizan, Caroline ; Vannier, Stephane ; Richter, Sebastian |
Zeitschrift: | Journal of NeuroInterventional Surgery, Jg. 15 (2023-11-02), S. e248- (94S.) |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1759-8478 (print) |
DOI: | 10.1136/jnis-2022-019527 |
Schlagwort: |
|
Sonstiges: |
|